Financial statements report the business activities and financial performance of a company. Learn how they are used by executives, investors, and lenders.
Separating out different elements of council accounts would make them more useful, writes the director of finance and ...
Stora Enso is preparing for the separation of its Swedish forest assets business into a new publicly listed company, expected to be completed during the first half of 2027. Stora Enso initiated a ...
February 2026 | SAINT HELIER, Jersey | CoinShares International Limited ('CoinShares'', 'the Company” or 'the Group”) (Nasdaq Stockholm: CS; US OTCQX: CNSRF), a global asset manager specialising in ...
CALGARY, AB / ACCESS Newswire / February 12, 2026 / GINSMS Inc. (TSXV:GOK) ("GINSMS" or the "Corporation") has announced its financial results for the fourth quarter and twelve months ended December 3 ...
Full-year 2025 revenues surpassed guidance, growing 10% year-over-year to reach $9.55 billion. This strong performance was powered by an all-time ...
STORA ENSO OYJ FINANCIAL STATEMENTS RELEASE 4 February 2026 at 8:30 EETHELSINKI, Feb. 4, 2026 /PRNewswire/ -- Q4/2025 (year-on-year)Sales decreased by 3% to EUR 2,254 (2,322) million, mainly ...
On 30 January 2026, the UK’s Financial Conduct Authority (FCA) opened a consultation on a new framework that would require listed companies to provide sustainability disclosures aligned with the draft ...
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2026 Earnings Call Transcript January 29, 2026 Takeda Pharmaceutical Company Limited misses on earnings expectations. Reported EPS is $0.2151 EPS, ...
Quarterly revenue of approximately $10.1 million Second straight quarter of over $1.1 million of positive adjusted EBITDA Fort Lauderdale, Florida–(Newsfile Corp. –) – ZEFIRO ...
CNW/ - (NYSE: LSPD) (TSX: LSPD) ("Lightspeed" or the "Company"), the unified omnichannel platform powering ambitious retail ...
4d
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026
US$82 Million in Pending Proposals Across Multiple Infectious Disease ProgramsUS$40 Million NIAID Funding Award Supports VXV-01 Development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results